NEUROCRINE BIOSCIENCES INC

NBIXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$2.9B

▲ 21.4% YoY

Net Income

$478.6M

▲ 40.2% YoY

EPS

$4.67

▲ 41.9% YoY

Cash

$713.0M

▲ 206.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.